Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Net Cash Flow (2017 - 2022)

Historic Net Cash Flow for Iterum Therapeutics (ITRM) over the last 6 years, with Q4 2022 value amounting to $546000.0.

  • Iterum Therapeutics' Net Cash Flow rose 10638.3% to $546000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was -$6.3 million, marking a year-over-year decrease of 14991.33%. This contributed to the annual value of $18.1 million for FY2024, which is 22118.32% up from last year.
  • As of Q4 2022, Iterum Therapeutics' Net Cash Flow stood at $546000.0, which was up 10638.3% from -$1.2 million recorded in Q3 2022.
  • In the past 5 years, Iterum Therapeutics' Net Cash Flow registered a high of $51.9 million during Q1 2021, and its lowest value of -$45.3 million during Q3 2018.
  • Over the past 5 years, Iterum Therapeutics' median Net Cash Flow value was -$918500.0 (recorded in 2021), while the average stood at $641500.0.
  • Per our database at Business Quant, Iterum Therapeutics' Net Cash Flow skyrocketed by 23402.23% in 2018 and then crashed by 58881.9% in 2019.
  • Iterum Therapeutics' Net Cash Flow (Quarter) stood at $4.9 million in 2018, then tumbled by 588.82% to -$24.1 million in 2019, then skyrocketed by 125.31% to $6.1 million in 2020, then crashed by 240.32% to -$8.6 million in 2021, then soared by 106.38% to $546000.0 in 2022.
  • Its Net Cash Flow was $546000.0 in Q4 2022, compared to -$1.2 million in Q3 2022 and -$9.6 million in Q2 2022.